By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TNI BioTech 

New York  New York     U.S.A.
Phone: n/a Fax: n/a



Company News
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card 7/28/2014 8:27:49 AM
TNI BioTech Establishes New Record Date For Spin-Off Stock Dividend Of Cytocom, Inc. Shares 7/15/2014 10:03:55 AM
TNI BioTech Signs Non-Exclusive Distribution Agreement For Lodonalâ„¢ For Cancer And Receives First Sale In Africa 6/25/2014 7:26:24 AM
TNI BioTech Cancels Proposed Reverse Split Of Its Common Stock 6/24/2014 7:11:05 AM
TNI BioTech Files Schedule 14A And Announces Annual Meeting 6/18/2014 11:08:53 AM
TNI BioTech Obtains Drug Approval For Sale Of Low Dose Naltrexone (LDN) From Government Of Malawi 5/6/2014 9:46:53 AM
TNI BioTech Announces Proposed Spin-Off Of Cytocom, Inc. 5/1/2014 9:12:12 AM
TNI BioTech Granted Additional Patent For Methods For Inducing Sustained Immune Response Of T-Cells 3/12/2014 10:52:13 AM
TNI BioTech Announces SEC Clearance Of Form 10 Registration Statement And Clears Way To Upgrade To A Higher Exchange 2/12/2014 9:34:23 AM
TNI BioTech Subsidiary Granted Certificate Of Free Sale By Nicaraguan Minister Of Health For Low Dose Naltrexone 12/4/2013 9:42:22 AM